Denosumab Fracture Intervention Randomized Placebo Controlled Trial in Japanese Patients With Osteoporosis
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
Evaluate the efficacy and safety of denosumab in the treatment of involutional
(postmenopausal and senile) osteoporotic subjects with prevalent fragility vertebral
fracture(s)